The preferred first-line therapy for glaucoma, SLT.
Designed specifically for selective laser trabeculoplasty (SLT), Solo™ allows you to perform quick and highly accurate glaucoma laser treatment customized to each individual patient’s response.
LiGHT Trial1 confirms SLT as preferred first-line therapy for glaucoma
The pivotal results of the multi-center LiGH trial compared the use of SLT versus drops as a first-line treatment for treatment-naive patients who had POAG or OHT over 36 months.
Daybreak Medical Product Range
We offer a comprehensive range of products suitable for all aspects of Ophthalmology across multiple World leading brands.